OGEN insider filings
ORAGENICS INC — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-07-07. Screen OGEN transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for OGEN between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — ORAGENICS INC
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-07 | 4 | Spencer John — Chief Financial Officer | Grant/award (A): 55,900 (derivative) @ $0 | EDGAR |
| 2026-01-22 | 4/A | Telling Fred — Director | Sale (S): 210 @ $0.94 · Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2025-12-15 | 4 | Huffman Janet — CEO and CFO | Grant/award (A): 250,000 (derivative) @ $0 | EDGAR |
| 2025-12-15 | 4 | Telling Fred — Director | Sale (S): 210 @ $0.94 · Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2025-12-15 | 4 | Giordano Natasha — Director | Grant/award (A): 38,320 (derivative) @ $0 · Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2025-12-15 | 4 | DUNTON ALAN W — Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2025-12-15 | 4 | KOSKI ROBERT C — Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2025-12-15 | 4 | GANDOLFO JOHN P — Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2025-12-15 | 4 | POPE CHARLES L — Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2025-06-18 | 4 | Odyssey Health, Inc. — 10% owner | Sale (S): 2,000 @ $4.46 · Sale (S): 5,044 @ $4.26 | EDGAR |
| 2025-06-16 | 4 | Odyssey Health, Inc. — 10% owner | Sale (S): 5,000 @ $4.27 · Sale (S): 5,000 @ $4.45 | EDGAR |
| 2024-12-13 | 4 | KOSKI ROBERT C — Director | Conversion (C): 5,000 · Conversion (C): 1,500,000 (derivative) | EDGAR |
| 2024-12-09 | 4 | DUNTON ALAN W — Director | Sale (S): 66 @ $0.36 | EDGAR |
| 2024-12-09 | 4 | Telling Fred — Director | Sale (S): 3,597 @ $0.36 | EDGAR |
| 2024-09-20 | 4 | Telling Fred — Director | Grant/award (A): 65,000 (derivative) @ $0 | EDGAR |
| 2024-09-20 | 4 | REDMOND J MICHAEL — President | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2024-09-20 | 4 | POPE CHARLES L — Director | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2024-09-20 | 4 | KOSKI ROBERT C — Director | Grant/award (A): 65,000 (derivative) @ $0 | EDGAR |
| 2024-09-20 | 4 | Huffman Janet — Chief Financial Officer | Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2024-09-20 | 4 | GANDOLFO JOHN P — Director | Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2024-09-20 | 4 | DUNTON ALAN W — Director | Grant/award (A): 65,000 (derivative) @ $0 | EDGAR |
| 2024-09-20 | 4 | Cassidy Bruce A. Sr. — Director | Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2024-09-20 | 4 | Murphy Kimberly M — Director | Grant/award (A): 27,083 (derivative) @ $0 | EDGAR |
| 2024-01-02 | 4 | REDMOND J MICHAEL — President | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2023-12-01 | 4 | Telling Fred — Director | Sale (S): 3,500 @ $3.57 | EDGAR |
| 2023-10-06 | 4 | GANDOLFO JOHN P — Director | Grant/award (A): 5,102 (derivative) @ $0 | EDGAR |
| 2023-10-06 | 4 | Cassidy Bruce A. Sr. — Director | Grant/award (A): 5,102 (derivative) @ $0 | EDGAR |
| 2023-08-10 | 4 | Telling Fred — Director | Grant/award (A): 25,000 @ $0 | EDGAR |
| 2023-08-10 | 4 | Murphy Kimberly M — CEO and President, Director | Grant/award (A): 25,000 @ $0 | EDGAR |
| 2023-08-10 | 4 | KOSKI ROBERT C — Director | Grant/award (A): 25,000 @ $0 | EDGAR |
| 2023-08-10 | 4 | Huffman Janet — CFO, Secretary and Treasurer | Grant/award (A): 15,000 @ $0 | EDGAR |
| 2023-08-10 | 4 | DUNTON ALAN W — Director | Grant/award (A): 25,000 @ $0 | EDGAR |
| 2023-08-10 | 4 | POPE CHARLES L — Director | Grant/award (A): 25,000 @ $0 | EDGAR |
| 2023-03-08 | 4 | Huffman Janet — CFO, Secretary and Treasurer | Grant/award (A): 7,000 (derivative) @ $0 | EDGAR |
| 2023-01-03 | 4 | KOSKI ROBERT C — Director | Sale (S): 36,648 @ $0.11 · Sale (S): 42,357 @ $0.11 | EDGAR |
| 2022-12-16 | 4 | KOSKI ROBERT C — Director | Sale (S): 25,000 @ $0.17 · Sale (S): 140,497 @ $0.18 | EDGAR |
| 2022-12-15 | 4 | KOSKI ROBERT C — Director | Sale (S): 4,503 @ $0.17 | EDGAR |
| 2022-12-12 | 4 | KOSKI ROBERT C — Director | Sale (S): 48,795 @ $0.20 | EDGAR |
| 2022-12-09 | 4 | KOSKI ROBERT C — Director | Sale (S): 13,036 @ $0.20 | EDGAR |
| 2022-12-01 | 4 | KOSKI ROBERT C — Director | Sale (S): 200,000 @ $0.19 · Sale (S): 200,000 @ $0.19 | EDGAR |
| 2022-08-02 | 4 | KOSKI ROBERT C — Director | Grant/award (A): 220,000 (derivative) @ $0 | EDGAR |
| 2022-08-02 | 4 | Sullivan Michael O'Keefe — Chief Financial Officer | Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2022-08-02 | 4 | Telling Fred — Director | Grant/award (A): 220,000 (derivative) @ $0 | EDGAR |
| 2022-08-02 | 4 | DUNTON ALAN W — Director | Grant/award (A): 220,000 (derivative) @ $0 | EDGAR |
| 2022-08-02 | 4 | POPE CHARLES L — Director | Grant/award (A): 220,000 (derivative) @ $0 | EDGAR |
| 2022-06-27 | 4/A | Telling Fred — Director | Grant/award (A): 250,000 (derivative) @ $0 | EDGAR |
| 2022-06-24 | 4 | Murphy Kimberly M — CEO and President, Director | Grant/award (A): 800,000 (derivative) @ $0 | EDGAR |
| 2022-06-24 | 4 | Sullivan Michael O'Keefe — Chief Financial Officer | Grant/award (A): 250,000 (derivative) @ $0 | EDGAR |
| 2022-06-24 | 4 | Telling Fred — Director | Grant/award (A): 250,000 (derivative) @ $0 | EDGAR |
| 2022-06-21 | 4 | Telling Fred — Director | Purchase (P): 10,084 @ $0.29 | EDGAR |
Recent 8-K events — ORAGENICS INC
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-09-16 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-28 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-06 | 8-K | 1.01 — Entry into a Material Definitive Agreement 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-19 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-07 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-13 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-31 | 8-K | ? 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-11 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-22 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-20 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=OGEN returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs